Ionis Pharmaceuticals logo
Ionis Pharmaceuticals IONS
$ 35.01 0.26%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Ionis Pharmaceuticals Financial Ratios 2011-2025 | IONS

Annual Financial Ratios Ionis Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-675.5 -99.8 -156.8 -18.9 28.3 27.0 -1096.0 -58.4 -52.8 -206.8 -91.0 -22.6 -9.7

P/S

19.3 34.4 5.5 11.5 7.4 12.3 12.9 14.6 16.4 37.6 37.5 14.5 8.3

EPS

-0.1 -0.4 -0.2 -3.2 2 2.1 0.1 -0.5 -0.7 -0.3 -0.6 -0.7 -0.8

EV (Enterprise Value)

8.46 B 6.92 B 5.46 B 9.54 B 9.2 B 8.6 B 7.32 B 5.78 B 5.29 B 8.62 B 5.83 B 1.72 B 1.07 B

EBITDA per Share

0.03 -1.37 -0.1 -1.14 2.73 -0.369 0.265 -0.308 -0.547 -0.326 -0.379 -0.578 -0.595

EV/EBITDA

-363.5 -57.0 22.1 -159.0 213.5 -147.2 -75.4 -216.7 -131.8 -25.9 -16.4

PEG

-35.24 12.11 0.52 0.07 19.75 -0.01 11.75 21.61 -0.42 5.17 5.92 0.96 -0.26

P/B

16.2 9.1 5.8 9.9 4.9 6.2 15.6 50.8 23.2 31.3 14.6 8.1 4.8

P/CF

-20.3 -19.1 145.6 233.7 26.9 12.6 48.0 -40.9 497.0 -1673.2 95.0 -448.5 -6.5

ROE %

-2.40 -9.15 -3.71 -59.77 17.46 23.06 -1.43 -86.93 -43.97 -15.12 -16.03 -35.83 -49.47

ROA %

-0.31 -2.07 -1.09 -18.59 9.10 10.26 -0.45 -9.49 -9.23 -4.08 -7.16 -12.00 -17.49

ROCE %

-1.58 -36.31 -3.91 -23.15 12.36 -2.57 2.24 -5.95 -9.39 -5.68 -6.89 -14.62 -17.39

Current Ratio

1.1 1.3 1.4 1.5 10.0 7.9 5.2 6.0 5.6 7.3 7.5 5.7 4.7

DSO

- - - - 20.5 7.8 45.3 113.8 14.6 6.7 27.5 1.9 25.5

DIO

1008.3 605.6 787.3 613.2 1513.6 1721.1 9.7 7.9 7.8 9.5 15.9 14.1 -

DPO

878.2 385.6 489.9 508.2 1337.7 5747.7 24.2 22.4 32.1 27.2 21.8 23.6 -

Operating Cycle

1008.3 605.6 787.3 613.2 1534.1 1728.9 55.0 121.7 22.4 16.1 43.4 16.0 -

Cash Conversion Cycle

130.1 220.0 297.4 105.1 196.4 -4018.9 30.7 99.3 -9.7 -11.0 21.6 -7.6 -

All numbers in USD currency

Quarterly Financial Ratios Ionis Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.95 -0.45 -0.98 - -1.03 -0.6 -0.87 - -0.33 -0.74 -0.46 1.59 -0.58 -0.57 -0.64 -2.54 -0.18 -0.18 -0.28 1.31 0.19 -0.01 0.63 2.32 -0.03 -0.29 -0.01 -0.03 -0.02 -0.02 0.07 0.21 0.06 -0.47 -0.52 -0.59 -0.3 0.3 -0.14 0.26 -0.23 -0.1 -0.27 -0.21 -0.21 -0.09 -0.02 -0.03 -0.37 -0.01 -0.24 - -0.27 -0.18 -0.2

EBITDA per Share

- - -1.01 - - - -0.78 - -0.34 -0.55 -0.38 1.56 -0.53 -0.46 -0.63 -0.16 -0.19 -0.33 -0.42 1.85 0.08 -0.09 0.9 0.08 -0.08 -0.35 -0.01 -0.05 0.14 0.08 0.17 0.34 0.18 -0.37 -0.44 -0.52 -0.36 0.4 -0.07 0.09 -0.14 -0.03 -0.24 -0.17 -0.18 -0.04 0.03 -0.26 -0.28 0.04 -0.18 -0.19 -0.22 -0.14 -0.16

ROE %

-141.22 -166.75 -161.53 -92.19 -100.10 -61.28 -58.19 -33.92 -4.81 -12.45 -9.50 -13.52 -90.33 -78.07 -67.64 -59.77 0.46 5.53 8.92 19.99 38.00 35.79 31.99 26.12 -5.46 -5.96 -3.20 0.12 27.14 35.45 -20.55 -86.93 -148.49 -173.69 -98.83 -43.97 3.66 11.13 -11.31 -15.12 -33.58 -32.85 -31.28 -19.59 -14.61 -25.60 -23.14 -35.83 -46.07 -41.16 -50.93 -49.47 -15.68 -10.43 -11.66

ROA %

-17.21 -17.68 -18.09 -12.20 -14.14 -11.06 -12.47 -8.81 -0.21 -1.68 -0.64 -2.05 -25.49 -23.09 -20.93 -18.59 1.95 3.78 4.83 9.10 15.39 14.41 12.93 10.26 -1.96 -1.98 -0.70 0.03 3.08 4.08 -1.91 -9.49 -19.86 -24.44 -14.44 -9.31 1.47 2.46 -2.57 -4.08 -10.19 -11.70 -11.82 -8.75 -6.37 -8.97 -7.80 -12.00 -15.65 -14.29 -17.76 -17.49 -5.54 -3.69 -4.12

ROCE %

-143.34 -166.32 -162.31 -89.93 -99.89 -64.42 -57.05 -31.74 -3.16 -9.39 -8.22 -13.63 -45.27 -34.00 -28.44 -23.15 -2.38 2.70 8.39 24.87 8.18 6.24 2.72 -5.86 -9.09 -3.29 3.80 11.05 54.59 66.74 15.31 -46.52 -119.20 -159.35 -87.98 -37.73 -2.48 13.16 -11.65 -18.52 -27.67 -26.08 -25.59 -13.65 -22.70 -31.30 -27.18 -37.71 -34.28 -31.95 -42.18 -41.47 -13.02 -8.20 -9.40

Current Ratio

1.3 1.1 1.1 1.1 1.1 1.2 1.2 1.3 1.3 1.3 1.4 1.4 1.3 1.3 1.4 1.4 1.4 1.4 1.4 2.1 2.1 2.1 2.1 1.8 1.8 1.8 1.8 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 1.8 1.8 1.8 1.8 1.5 1.5 1.5 1.5 1.6 1.6 1.6 1.6

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

2435.7 646.3 1244.8 - 1065.6 858.5 1502.7 - 1218.3 421.6 534.4 - 696.9 714.1 781.6 - 649.5 665.4 718.8 - 1715.5 1216.2 1172.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

779.4 244.6 829.5 - 617.1 620.8 965.5 - 930.5 254.6 306.7 - 341.0 372.7 472.6 - 508.6 521.0 595.7 - 1516.2 1074.9 1960.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

2435.7 646.3 1244.8 - 1065.6 858.5 1502.7 - 1218.3 421.6 534.4 - 696.9 714.1 781.6 - 649.5 665.4 718.8 - 1715.5 1216.2 1172.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

1656.3 401.6 415.2 - 448.5 237.7 537.2 - 287.9 167.0 227.7 - 355.8 341.4 309.0 - 140.9 144.4 123.2 - 199.4 141.4 -787.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency